Volume 15; Issue 4

Main
Investigational New Drugs
Volume 15; Issue 4

Investigational New Drugs

Volume 15; Issue 4

1

A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma

William J. Berg, Lawrence H. Schwartz, Alison Amsterdam, Madhu Mazumdar, Vaia Vlamis, Teresa Murray Law, David M. Nanus, Robert J. Motzer

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 27 KB

english, 1997

2

Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-α (PKC-α) pseudosubstrate peptides through a P-glycoprotein-independent mechanism

Philip J. Bergman, Karen R. Gravitt, Nancy E. Ward, Pedro Beltran, Krishna P. Gupta, Catherine A. O'Brian

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 341 KB

english, 1997

3

Preclinical toxicity of a new oral anticancer drug, CI-994 (Acetyldinaline), in rats and dogs

Michael J. Graziano, Gary D. Pilcher, Kathleen M. Walsh, Olajide B. Kasalil, Louis Radulovic

Journal:

Investigational New Drugs

Year:

1997

File:

PDF, 1.07 MB

1997

4

Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)

John S. Macdonald, Jacqueline K. Benedetti, Manuel Modiano, David S. Alberts

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 24 KB

english, 1997

5

Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies

John D. Hainsworth, Susan M. Utley, F. Anthony Greco

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 37 KB

english, 1997

6

Il-4r expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4)

Jie Cai, Tong Zheng, John Murphy, Cory A. Waters, George Y. Lin, Parkash S. Gill

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 1.08 MB

english, 1997

7

An in vitro assessment of the antineoplastic potential of 2H-1,3-Oxazine-2,6(3H)-dione (3-oxauracil), a novel pyrimidine

Lawton Seal, Daniel Von Hoff, Richard Lawrence, Elzbieta Izbicka, Richard M. Jamison

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 65 KB

english, 1997

8

A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors

Randall Brand, Mary Capadano, Margaret Tempero

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 72 KB

english, 1997

9

An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92

Joan H. Schiller, Donna Neuberg, Dan Burns, Paul Ritch, Marilyn Larson, Mark Levitt, Janice Dutcher

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 48 KB

english, 1997

10

Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer

Jivesh J. Sharma, Betty Razvillas, C.D. Stephens, Susan G. Hilsenbeck, Ashu Sharma, Mace L. Rothenberg

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 37 KB

english, 1997

11

Multiple resistance modulators combined with carboplatin for resistant malignancies: A pilot study

David J. Stewart, Rakesh Goel, M. Christine Cripps, Susan Huan, Jonathan Yau, Shailendra Verma

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 76 KB

english, 1997